biopharmapatent
Wednesday, October 17, 2018
IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union
https://www.nasdaq.com/press-release/imraldi-biogens-adalimumab-biosimilar-referencing-humira-is-launched-in-the-european-union-20181017-00050
Newer Posts
Older Posts
Home
Subscribe to:
Posts (Atom)
